Call to Schedule Free Consultation at Over 80 Centers Worldwide!

(844) GET-STEM

From Chronic Back Pain to World Champion: Santino Marella’s Experience

Written by Dr. David Greene, MD, PhD, MBA on August 7, 2026

Table of Contents

Years of high-impact physical exertion take a severe toll on the human musculoskeletal system. For professional athletes, chronic spinal degeneration, joint wear, and persistent inflammation often extend well beyond their active careers, making everyday movement difficult.

In this case review, former WWE superstar and current TNA wrestler Anthony Carelli (known professionally as Santino Marella) shares his experience using advanced regenerative medicine to address severe physical limitations, restore daily mobility, and compete at an elite level past age 50.

The Physical Toll of High-Impact Athletics

Professional wrestling and combat sports involve constant axial loading, repeated blunt impact, and micro-trauma to the intervertebral discs and peripheral joints. Over time, these forces cause structural changes, including:

Intervertebral Disc Degeneration: Loss of disc height, hydration, and mechanical integrity leading to spinal stiffness and nerve impingement.

Chronic Neurogenic & Muscular Pain: Persistent inflammation around spinal nerves, causing severe morning stiffness and dynamic instability.

Cumulative Soft Tissue Damage: Micro-tearing of ligaments and tendons that fails to heal fully through traditional rest and conservative physical therapy.

Before turning to biologic interventions, Carelli experienced daily mobility restrictions so severe that basic functional movements, such as sitting up in bed each morning, were painful and challenging. Athletes facing similar physical wear often explore options like stem cell therapy for a range of athletic and sports injuries to regain baseline function.

Exploring Biologic Therapies: Components of the Treatment Plan

To address both local structural tissue wear and broader inflammatory responses, Carelli’s treatment protocol utilized a comprehensive array of regenerative biologics:

1. Umbilical Cord-Derived Mesenchymal Stem Cells (MSCs)

Allogeneic stem cells harvested from ethically donated post-birth umbilical cord tissue provide robust regenerative potential. Readers interested in understanding umbilical cord stem cell therapy often note that, unlike autologous bone marrow or adipose-derived cells collected from older patients, umbilical cord MSCs maintain higher proliferative capacity and secrete signaling proteins that modulate inflammation and encourage local cell recruitment.

2. Wharton’s Jelly

What is umbilical cord Wharton’s jelly comes down to its role as the supportive, gelatinous connective tissue found within the umbilical cord. Rich in extracellular matrix components, extracellular vesicles, cytokines, and high-molecular-weight hyaluronic acid, it serves as a natural structural scaffold when injected into damaged joint spaces or spinal tissues.

3. Exosomes

Exosomes are cell-derived extracellular vesicles that mediate intercellular communication. When evaluating exosomes vs stem cells, clinicians highlight how these microscopic vesicles carry essential proteins, growth factors, and microRNA. This payload helps regulate cellular stress responses, suppress pro-inflammatory signaling pathways, and stimulate tissue repair processes in neighboring cells.

4. Platelet-Rich Plasma (PRP)

Derived from a patient’s own peripheral blood, platelet-rich plasma therapy contains concentrated platelets rich in platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-$\beta$), and vascular endothelial growth factor (VEGF). When combined with tissue-derived biologics, PRP enhances local vascular response and accelerates tissue repair.

Precise Anatomical Targeting: The Role of Image Guidance

The effectiveness of musculoskeletal biologics depends heavily on accurate delivery into the targeted anatomical tissue. Biologics injected into surrounding musculature rather than the precise joint capsule, epidural space, or damaged ligamentous complex yield significantly diminished clinical outcomes.

During Carelli’s procedure, clinicians utilized image-guided protocols similar to those taught in MSK orthopedic ultrasound injection training to visualize needle trajectories in real time. Ultrasound imaging allows the medical team to:

Identify specific anatomical landmarks, joints, and soft tissue pathologies.

Avoid neurovascular structures during needle passage.

Confirm real-time fluid deposition within the designated therapeutic zone.

Clinical Evidence and Real-World Outcomes

While peer-reviewed research on orthopedic biologics continues to evolve, clinical trials and observational studies show promising results for regenerative therapies in treating degenerative spine and joint conditions:

Pain Reduction: Studies demonstrate significant pain reduction in patients receiving targeted mesenchymal stem cell and autologous PRP injections for chronic lumbar disc disease and peripheral osteoarthritis.

Functional Recovery: Patient-reported outcome measures consistently show improvements in flexibility, daily activity tolerance, and physical performance following regenerative interventions.

Safety Profile: Screening protocols for allogeneic birth tissue products ensure low immunogenicity and a favorable safety profile when procedures are performed by certified clinicians using aseptic techniques.

For Carelli, regenerative therapy enabled a return to high-level functional conditioning, culminating in a 2025 age-group World Championship win. His case demonstrates how modern strategies in regenerative medicine for orthopedics can help manage chronic orthopedic pain and support athletic recovery alongside proper physical conditioning and medical care.

Partnering with Leading Centers in Regenerative Care

When patients begin choosing a regenerative medicine clinic, selecting a qualified medical provider is a crucial step for treating chronic pain or athletic injuries. High-quality care relies on thoroughly screened biologic products, strict laboratory safety standards, and experienced clinicians trained in image-guided delivery.

Providers like R3 Stem Cell focus on evidence-aware regenerative protocols, using rigorous quality controls for all birth-tissue biologics and utilizing precision imaging—such as ultrasound and fluoroscopy—to ensure optimal clinical placement and patient safety.

Contact Us